Jan 13, 2026 7:01am EST Pasithea Therapeutics Provides Outlook on PAS-004 Clinical Programs and Data Release Timelines
Dec 2, 2025 7:00am EST Pasithea Therapeutics Announces Closing of $60 Million Public Offering of Common Stock